Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
December 30, 2016 7:02 AM 2 min read

2016's Worst ETFs: International Illness And Healthcare Sickness

by Todd Shriber, ETF Professor Benzinga Staff Writer
Follow

Looking at the bad can, at times, underscore the good. For example, domestic equities have been solid this year to the point that just 70 exchange traded funds sport year-to-date losses of 30 percent or more.

Exclude leveraged exchange traded funds and volatility products, and the list dwindles further.

As has been widely noted, the healthcare sector, the third-larges sector weight in the S&P 500, is cruising toward its first annual loss since 2008. So it's not surprising that a focused healthcare ETF such as the BioShares Biotechnology Clinical Trials ETF (NASDAQ: BBC) has been punished. Plenty of healthcare ETFs have been drubbed this year, thanks in large part to election year campaign rhetoric, but BBC is down almost 37 percent.

It has also been a brutal year for solar stocks and ETFs.

The VanEck Vectors Solar Energy ETF (NYSE: KWT) and the Guggenheim Solar ETF (NYSE: TAN) are both down more than 42 percent year-to-date. Making matters for solar stocks is that the group slumped against the backdrop of higher oil prices. The energy sector is this year's best-performing sector, a catalyst that would normally lift solar equities.

TAN has been stymied on multiple fronts this year. In previous periods of rising oil prices, solar stocks and TAN have participated in some of that upside, but that's not the case this year. Second, short sellers have been voraciously attacking some TAN constituents, a frequent occurrence with this exchange-traded fund, and winning.

Some international ETFs have been drubbed as well. Political volatility and concerns over the fragility of Italian banks have sent the iShares Currency Hedged MSCI Italy (NYSE: HEWI) lower by nearly 31 percent, a staggering decline given the euro's recent weakness. To be fair, HEWI has shown some signs of life this month.

The VanEck Vectors Egypt ETF (NYSE: EGPT) is also down more than 31 percent this year with nearly all of that decline being accrued in the current quarter.

The Global X MSCI Nigeria ETF (NYSE: NGE) is down 39.3 percent this year. On its own, that's a bad statistic, but it's a true indictment of NGE when considering oil prices are higher and major frontier markets benchmarks have not declined nearly as much. NGE is Africa's largest oil producer and a member of the Organization of Petroleum Exporting Countries.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
BiotechSector ETFsShort IdeasEmerging Market ETFsTop StoriesTrading IdeasETFsGeneral
BBC Logo
BBCVirtus LifeSci Biotech Clinical Trials ETF
$39.87-1.06%
Overview
TAN Logo
TANInvesco Solar ETF
Not Available-%
KWT Logo
KWTiShares MSCI Kuwait ETF
$37.130.05%
BBC Logo
BBCVirtus LifeSci Biotech Clinical Trials ETF
$39.87-1.06%
Overview
TAN Logo
TANInvesco Solar ETF
Not Available-%
KWT Logo
KWTiShares MSCI Kuwait ETF
$37.130.05%
Comments
Loading...